Science Explorer Back to mapMap
Discussion
Company · Glasgow · United Kingdom

R-Biopharm (United Kingdom)

r-biopharm.comROR OpenAlex
Research works
20
▲ 43% vs 2018-21
Citations
450
22.9 per fractional work
Top-10% rate
4.9%
all institutions 10.0%
Open access
42%
world 40%
International
24%
world 18%
R-Biopharm (United Kingdom)

Not ranked overall: R-Biopharm (United Kingdom) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does R-Biopharm (United Kingdom) work in?

In all years, 67% of research at R-Biopharm (United Kingdom) is in Life Sciences, 20% in Health Sciences. Its largest fields are Agricultural and Biological Sciences (44%), Biochemistry, Genetics and Molecular Biology (19%), Medicine (17%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 13 fractional works · 67.1% of its workAgricultural and Biological Sciences: 9 fractional works · 43.6% of its workPlant Science: 4 fractional works · 21.5% of its workFood Science: 3 fractional works · 17.3% of its workAnimal Science and Zoology: 1 fractional works · 3.1% of its workInsect Science: 0 fractional works · 1.7% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 19.1% of its workMolecular Biology: 2 fractional works · 7.7% of its workBiotechnology: 1 fractional works · 7.2% of its workCell Biology: 1 fractional works · 3.4% of its workCancer Research: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 3.1% of its workMicrobiology: 0 fractional works · 2.5% of its workImmunology: 0 fractional works · 0.6% of its workNeuroscience: 0 fractional works · 1.3% of its workBehavioral Neuroscience: 0 fractional works · 0.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Sciences: 4 fractional works · 20.4% of its workMedicine: 3 fractional works · 17.4% of its workDermatology: 1 fractional works · 5.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.7% of its workRheumatology: 1 fractional works · 2.6% of its workOncology: 0 fractional works · 1.4% of its workSurgery: 0 fractional works · 0.9% of its workPhysiology: 0 fractional works · 0.9% of its workHematology: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Professions: 1 fractional works · 3.0% of its workMedical Laboratory Technology: 0 fractional works · 2.5% of its workEmergency Medical Services: 0 fractional works · 0.4% of its workPhysical Sciences: 2 fractional works · 12.6% of its workChemistry: 1 fractional works · 6.9% of its workAnalytical Chemistry: 1 fractional works · 4.2% of its workOrganic Chemistry: 0 fractional works · 2.1% of its workSpectroscopy: 0 fractional works · 0.6% of its workEnvironmental Science: 1 fractional works · 3.1% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 3.1% of its workMaterials Science: 0 fractional works · 2.5% of its workMaterials Chemistry: 0 fractional works · 2.5% of its workALL ITS WORKR-Biopharm(United Kingdom)20fractional works, all years
Life Sciences67%Physical Sciences13%Health Sciences20%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Agricultural and Biological Sciences943.6%
    2. Biochemistry, Genetics and Molecular Biology419.1%
    3. Immunology and Microbiology13.1%
    4. Neuroscience01.3%
    1. Medicine317.4%
    2. Health Professions13.0%
    1. Chemistry16.9%
    2. Environmental Science13.1%
    3. Materials Science02.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 6.54× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.34× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.97× its world share, 0 worksImmunology and Micro…Neuroscience: 5.38× its world share, 0 worksNeuroscienceChemistry: 1.86× its world share, 0 worksChemistryEnvironmental Science: 3.13× its world share, 0 worksEnvironmental ScienceMedicine: 0.76× its world share, 0 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Agricultural and Biological Sciences, 6.5×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Agricultural and Biological Sciences6.54×1 works
  2. Neuroscience5.38×0 works
  3. Biochemistry, Genetics and Molecular Biology4.34×1 works
  4. Immunology and Microbiology3.97×0 works
  5. Environmental Science3.13×0 works
  6. Chemistry1.86×0 works
  7. Medicine0.76×0 works

Who are the top researchers at R-Biopharm (United Kingdom)?

Ranked on the quality score, Carol M. Donnelly and Elaine Marley lead among researchers whose main affiliation is R-Biopharm (United Kingdom).

  1. 1 Carol M. Donnelly United Kingdom · #2,887,997 worldwide 932 citations · 22 works
  2. 2 Elaine Marley United Kingdom · #3,840,799 worldwide 476 citations · 22 works
All ranked researchers at R-Biopharm (United Kingdom)

What are the most cited papers from R-Biopharm (United Kingdom)?

The most cited paper from R-Biopharm (United Kingdom) is "Albumin and its application in drug delivery" (Darrell Sleep, 2014), with 478 citations. Next come "Common causes of blindness and visual handicap in the west of Scotland." (309) and "Determination of Vitamin B12 in food products and in premixes by reversed-phase high performance liquid chromatography and immunoaffinity extraction" (121).

Most cited papers
#PaperReleasedCitations
1 Albumin and its application in drug delivery Darrell Sleep · Expert Opinion on Drug Delivery 18 Dec 2014 478
2 Common causes of blindness and visual handicap in the west of Scotland. I M Ghafour, D Allan, Wallace S. Foulds · British Journal of Ophthalmology Open access Apr 1983 309
3 Determination of Vitamin B12 in food products and in premixes by reversed-phase high performance liquid chromatography and immunoaffinity extraction Olivier Heudi, Tamara Kilinç, Patric Fontannaz et al. · Journal of Chromatography A 11 Oct 2005 121
4 The use of immunoaffinity columns connected in tandem for selective and cost-effective mycotoxin clean-up prior to multi-mycotoxin liquid chromatographic–tandem mass spectrometric analysis in food matrices Joyce Wilcox, Carol M. Donnelly, David Leeman et al. · Journal of Chromatography A 5 May 2015 51
5 Characterisation of vitamin B12 immunoaffinity columns and method development for determination of vitamin B12 in a range of foods, juices and pharmaceutical products using immunoaffinity clean-up and high performance liquid chromatography with UV detection Elaine Marley, Eric James Mackay, Gregory S. Young · Food Additives & Contaminants Part A Open access Mar 2009 33
All 34 most cited papers, with filters and sorting

Which research topics does R-Biopharm (United Kingdom) publish most on?

By volume in 2022-now: Indoor Air Quality and Microbial Exposure, Mycotoxins in Agriculture and Food, Pesticide Residue Analysis and Safety and RNA Interference and Gene Delivery.

Indoor Air Quality and M…0Indoor Air Quality and Microbial Exposure: 0 fractional worksMycotoxins in Agricultur…0Mycotoxins in Agriculture and Food: 0 fractional worksPesticide Residue Analys…0Pesticide Residue Analysis and Safety: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksSingle-cell and spatial transcriptomics: 0 fractional worksRNA Research and Splicing: 0 fractional worksChemical synthesis and alkaloids: 0 fractional worksCholinesterase and Neurodegenerative Diseases: 0 fractional worksRegulation of Appetite and Obesity: 0 fractional worksStress Responses and Cortisol: 0 fractional works
Health, Toxicology and MutagenesisPlant ScienceFood ScienceMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Indoor Air Quality and Microbial Exposure Health, Toxicology and Mutagenesis 0 works
  2. 2 Mycotoxins in Agriculture and Food Plant Science 0 works
  3. 3 Pesticide Residue Analysis and Safety Food Science 0 works
  4. 4 RNA Interference and Gene Delivery Molecular Biology 0 works
  5. 5 Single-cell and spatial transcriptomics Molecular Biology 0 works
  6. 6 RNA Research and Splicing Molecular Biology 0 works
  7. 7 Chemical synthesis and alkaloids Organic Chemistry 0 works
  8. 8 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
  9. 9 Regulation of Appetite and Obesity Endocrine and Autonomic Systems 0 works
  10. 10 Stress Responses and Cortisol Behavioral Neuroscience 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.7%not open58.3%

World: 40% of research is openly available.

with international co-authors23.6%domestic only76.4%

World: 18% is written across borders.

How has R-Biopharm (United Kingdom)'s research output changed?

Output in 2022-2025 was 43% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is R-Biopharm (United Kingdom) as a percentage of every work published that year, 0.0000090% in 2024.

still counting0.00020%0.00040%0.00060%R-Biopharm (United Kingdom)0.000012% in 202519801990200020102020

Fractional works of R-Biopharm (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Glasgow

All research institutions in Glasgow

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about R-Biopharm (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.